We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 23

Fundamentals of Canadian product liability - duty to warn
  • Gowling WLG
  • Canada
  • October 4 2011

A manufacturer has a duty to warn consumers and others in the supply chain of all material risks of which it is aware, or of which it ought to be aware, resulting from ordinary use of its product.


Board follows guidelines in Penlac decision
  • Gowling WLG
  • Canada
  • February 7 2011

On February 3, 2011, the Patented Medicine Prices Review Board (the Board) released its decision dated January 31, 2011, regarding Penlac, a drug manufactured by sanofi-aventis.


Volatile Organic Compound (VOC) Concentration Limits for Architectural Coatings Regulations
  • Gowling WLG
  • Canada
  • November 23 2009

The Federal government issued the Volatile Organic Compound (VOC) Concentration Limits for Architectural Coatings Regulations ("Regulations") on September 30, 2009.


Order amending the Domestic Substances List re Disperse Orange 5
  • Gowling WLG
  • Canada
  • November 23 2009

On September 16, 2009, the Ministers of Environment and Health published Order 2009-87-05-04 that amends the DSL by deleting Ethanol, 2-4-(2, 6-dichloro-4-nitrophenyl)azophenylmethylamino- ("Disperse Orange 5") from Part 1 and adding it to Part 2 with the letter 'S' following the substance identification number.


Order amending the Domestic Substances List to add 19 substances
  • Gowling WLG
  • Canada
  • November 23 2009

On September 16, 2009, the Ministers of Environment and Health published Order 2009-87-07-01 pursuant to s. 87(1) of the Canadian Environmental Protection Act, 1999.


Notice for Batch 11 substances
  • Gowling WLG
  • Canada
  • November 23 2009

On September 26, 2009, the Federal government provided notice pursuant to s. 71(1)(b) of the Environmental Protection Act, 1999 that the Minister of Environment requires any person who manufactured or imported a total quantity 100 kg of a listed substance whether alone, in a mixture, in a product, or in a manufactured item, or used a total quantity 1000 kg of a listed substance at any concentration, whether alone, in a mixture, in a product or in a manufactured item during the 2006 calendar year, to provide the prescribed information.


Notice with respect to micro-organisms on the Domestic Substances List
  • Gowling WLG
  • Canada
  • November 23 2009

On October 3, 2009, the Minister of Environment gave notice pursuant to paragraph 71(1)(b) of the Canadian Environmental Protection Act, 1999 to prescribed persons that information is required from them for the purpose of assessing whether the substances listed in Schedule 1 to the notice are toxic or are capable of becoming toxic, or for the purpose of assessing whether to control, or the manner in which to control the listed substances.


Toxic Reductions Act
  • Gowling WLG
  • Canada
  • July 16 2009

The Toxic Reductions Act was passed by the Ontario Legislature on June 3, 2009.


FDA approves guidelines to inform doctors of "off-label uses" for medicine and medical devices
  • Gowling WLG
  • USA
  • January 19 2009

The United States Food and Drug Administration (FDA) recently finalized guidelines which will allow pharmaceutical companies to inform doctors about unapproved uses of medicines and medical devices.


Increased competition for generic drugs could save Canadians $800 million a year
  • Gowling WLG
  • Canada
  • November 26 2008

The Competition Bureau has released a new study of the generic drug industry, Benefiting from Generic Drug Competition in Canada: The Way Forward, that proposes a number of changes to increase competition in the supply of generic drugs.